‘Counterintuitive:’ Medical experts weigh in on side effects of FDA approved weight loss drug
ROCHESTER, N.Y. (WROC) — The Federal Drug Administration has approved the rebranding of a diabetes drug to help manage weight loss. This comes after the increase in popularity of Wegovy and Ozempic over the last year. While diabetic drug 'Mounjaro' has already been used by some patients as an 'off-label' for weight loss, the FDA's recent approval will allow the drugmaker to officially rebrand itself as 'Zepbound.' FDA approves blockbuster drug […]
Post comments (0)